From Tuberculosis to COVID-19: How These Assays Are Shaping Public Health
The impact of ELISpot and FluoroSpot assays extends far beyond the research lab and into the realm of public health. For decades, ELISpot has been a crucial tool for diagnosing latent tuberculosis infections, helping clinicians identify and treat at-risk individuals before the disease can progress. More recently, during the COVID-19 pandemic, these assays played a vital role in understanding the immune response to the virus and in evaluating the effectiveness of vaccines. They provided the critical data needed to measure T-cell immunity and helped scientists predict how long protection would last. This ability to provide precise, actionable data on cellular immunity is making these assays indispensable tools in the global fight against infectious diseases. The use of these assays in public health initiatives is a major driver of the ELISpot and FluoroSpot Assay Market.